Our coverage of the Zika outbreak.
Various governments and pharmaceutical companies are pushing for intensified research as the Zika virus continues to spread. While there is currently no vaccine or treatment available, several companies have already come forward committing to vaccine development.
07-Dec-2016 - As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and...
27-Jul-2016 - Inovio Pharmaceuticals and GeneOne Life Science have dosed the first patient in the multi-center, phase I clinical trial of the companies’ Zika vaccine.
12-May-2016 - Researchers have developed a new mouse model that allows them to ask different questions about the effects of the Zika virus.
14-Apr-2016 - Replikins’ genomic understanding of the Zika and Flaviviruses has led to the development of a trivalent vaccine for Zika, Dengue, and Japanese Encephalitis.
06-Apr-2016 - Researchers have established a new mouse model for testing vaccines and therapeutics to fight the Zika virus.
15-Mar-2016 - Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
17-Feb-2016 - Ennaid Therapeutics has announced it is developing therapeutic cures to help those that may become infected with the Zika Virus , and it may be available in less than four years.
15-Feb-2016 - Zika researchers are using animal models and epidemiological studies to try and determine if the virus causes birth defects and neurological disorders.
03-Feb-2016 - Sanofi Pasteur has launched a Zika vaccine project, levering its experience in developing vaccines for similar viruses, as the US government pushes for “intensified research.”